The role of the AT2 receptor in hypertension

American Journal of Hypertension

Volumn 13, Issue 5 II SUPPL., 2000, Pages

  Siragy, Helmy M ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Angiotensin II; Angiotensin II subtype 1 receptor blockers; Angiotensin converting enzyme inhibitor; Bradykinin

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BRADYKININ; CANDESARTAN; CYCLIC GMP; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPROSARTAN; G PROTEIN COUPLED RECEPTOR; GROWTH PROMOTOR; IRBESARTAN; LOSARTAN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN E2; TELMISARTAN; VALSARTAN; ANGIOTENSIN RECEPTOR;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CONTROLLED STUDY; HEMODYNAMICS; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HUMAN; HYPERTENSION; KIDNEY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASOCONSTRICTION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

HUMANS; HYPERTENSION; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN;

EID: 0034186166     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(00)00274-0     Document Type: Article

References (46)

1. Dzau VJ: Implications of local angiotensin production in cardiovascular physiology and pharmacology. Am J Cardiol 1987;59:59A-65A.
2. Wilkes BM, Mento PF, Pearl AR, Hollander AM, Mossey RT, Bellucci A, Bluestone PA, Mailloux LU: Plasma angiotensins in anephric humans: evidence for an extrarenal angiotensin system. J Cardiovasc Pharmacol 1991;17:419-423.
3. Horiuchi M, Akishita M, Dzau VJ: Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension 1999;33:613-621.
4. 1 receptor. J Hypertens 1992;10:1463-1469.
5. Brilla CG, Janicki JS, Weber KT: Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation 1991;83:1771-1779.
6. Brilla CG, Zhou G, Matsubara L, Weber KT: Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol 1994;26:809-820.
7. Zitnay C, Siragy HM: Action of angiotensin receptor subtypes on the renal tubules and vasculature: implications for volume homeostasis and atherosclerosis. Miner Electrolyte Metab 1998;24:362-370.
8. Siragy HM, Bedigian M: Mechanism of action of angiotensin-receptor blocking agents. Current Hypertension Reports 1999;1:289-295.
9. Tanabe A, Naruse M, Arai K, Naruse K, Yoshimoto T, Seki T, Imaki T, Miyazaki H, Zeng ZP, Demura R, Demura H: Gene expression and roles of angiotensin II type 1 and type 2 receptors in human adrenals. Horm Metab Res 1998;30:490-495.
10. 2 receptors in the pressor, drinking and vasopressin responses to central angiotensin. Brain Res 1992;586:289-294.
11. 1 receptor subtype. Eur J Pharmacol 1992;225:57-62.
12. Pfeilschifter J, Bauer C: Pertussis toxin abolishes angiotensin II-induced phosphoinositide hydrolysis and prostaglandin synthesis in rat renal mesangial cells. Biochem J 1986;236:289-294.
13. Catt KJ, Balla T, Baukal AJ, Hausdorff WP, Aguilera G: Control of glomerulosa cell function by angiotensin II: transduction by G-proteins and inositol polyphosphates. Clin Exp Pharmacol Physiol 1988;15:501-515.
14. Alexander RW, Brock TA, Gimbrone MA Jr, Rittenhouse SE: Angiotensin increases inositol trisphosphate and calcium in vascular smooth muscle. Hypertension 1985;7:447-451.
15. Dzau VJ, Sasamura H, Hein L: Heterogeneity of angiotensin synthetic pathways and receptor subtypes: physiological and pharmacological implications. J Hypertens 1993;11(suppl 3):S13-S18.
16. Sasamura H, Hein L, Krieger JE, Pratt RE, Kobilka BK, Dzau VJ: Cloning, characterization, and expression of two angiotensin receptor (AT-1) isoforms from the mouse genome. Biochem Biophys Res Commun 1992; 185:253-259.
17. Whitebread S, Mele M, Kamber B, de Gasparo M: Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem Biophys Res Commun 1989;163:284-291.
18. Chiu AT, Herblin WF, McCall DE, Ardecky RJ, Carini DJ, Duncia JV, Pease LJ, Wong PC, Wexler RR, Johnson AL, Timmermans PBMWM: Identification of angiotensin II receptor subtypes. Biochem Biophys Res Commun 1989;165:196-203.
19. 2 receptor: fact, fancy and fantasy. Regul Pept 1999;81:11-24.
20. Griendling KK, Murphy TJ, Alexander RW: Molecular biology of the renin-angiotensin system. Circulation 1993;87:1816-1828.
21. de Gasparo M, Levens N: Does blockade of angiotensin II receptors offer clinical benefits over inhibition of angiotensin-converting enzyme? Pharmacol Toxicol 1998;82:257-271.
22. 2 receptors in the developing rat fetus. J Clin Invest 1991;88:921-933.
23. 2 receptor binding sites in the adventitia of human kidney vasculature. Clin Exp Pharmacol Physiol Suppl 1996;3:S147-S154.
24. Nora EH, Munzenmaier DH, Hansen-Smith FM, Lombard JH, Greene AS: Localization of the ANG II type 2 receptor in the microcirculation of skeletal muscle. Am J Physiol 1998;275(4 pt 2):H1395-H1403.
25. Regitz-Zagrosek V, Fielitz J, Fleck E: Myocardial angiotensin receptors in human hearts. Basic Res Cardiol 1998;93:S037-S042.
26. Janiak P, Pillon A, Prost JF, Vilaine JP: Role of angiotensin subtype 2 receptor in neointima formation after vascular injury. Hypertension 1992;20:737-745.
27. Nio Y, Matsubara H, Murasawa S, Kanasaki M, Inada M: Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest 1995;95:46-54.
28. Ohkubo N, Matsubara H, Nozawa Y, Mori Y, Murasawa S, Kijima K, Maruyama K, Masaki H, Tsutumi Y, Shibazaki Y, Iwasaka T, Inada M: Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism. Circulation 1997;96:3954-3962.
29. 2) receptor protein in rat kidney. Hypertension 1997;30:1238-1246.
30. 2 receptors in the rat skin during experimental wound healing. Peptides 1992;13:783-786.
31. Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, Fogo A, Niimura F, Ichikawa I, Hogan BL, Inagami T: Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 1995;377:748-750.
32. Yamada T, Akishita M, Pollman MJ, Gibbons GH, Dzau VJ, Horiuchi M: Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antagonizes angiotensin II type 1 receptor action: an in vitro gene transfer study. Life Sci 1998;63:PL-289-PL-295.
33. 2 production in conscious rats. J Clin Invest 1996;97:1978-1982.
34. Ignarro LJ: Endothelium-derived nitric oxide: actions and properties. FASEB J 1989;3:31-36.
35. 2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest 1997;100:264-269.
36. Siragy HM, Jaffa AA, Margolius HS, Carey RM: Renin-angiotensin system modulates renal bradykinin production. Am J Physiol 1996;271(4 pt 2):R1090-R1095.
37. 2 receptor in a renal wrap hypertension model. Hypertension 1999;33:1237-1242.
38. 2) angiotensin receptor. Proc Natl Acad Sci USA 1999;96:6506-6510.
39. Endo Y, Arima S, Yaoita H, Omata K, Tsunoda K, Takeuchi K, Abe K, Ito S: Function of angiotensin II type 2 receptor in the postglomerular efferent arteriole. Kidney Int 1997;52(suppl 63):S-205-S-207.
40. Jin X-H, Siragy HM, Guerrant RL, Carey RM: Compartmentalization of extracellular cGMP determines absorptive or secretory responses in the rat jejunum. J Clin Invest 1999;103:167-174.
41. Jin X-H, Wang Z-Q, Siragy HM, Guerrant RL, Carey RM: Regulation of jejunal sodium and water absorption by angiotensin subtype receptors. Am J Physiol 1998; 275(2 pt 2):R515-R523.
42. Staessen J, Lijnen P, Fagard R, Verschueren LJ, Amery A: Rise in plasma concentration of aldosterone during long-term angiotensin II suppression. J Endocrinol 1981;91:457-465.
43. Biollaz J, Brunner HR, Gavras I, Waeber B, Gavras H: Antihypertensive therapy with MK 421: angiotensin II-renin relationships to evaluate efficacy of converting enzyme blockade. J Cardiovasc Pharmacol 1982;4: 966-972.
44. Urata H, Boehm KD, Philip A, Kinoshita A, Gabrovsek J, Bumpus FM, Husain A: Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart. J Clin Invest 1993;91:1269-1281.
45. Gainer JV, Morrow JD, Loveland A, King DJ, Brown NJ: Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects. N Engl J Med 1998; 339:1285-1292.
46. Israili ZH, Hall WD: Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann Intern Med 1992;117:234-242.